What is Eagle Pharmaceuticals' stock symbol?
Eagle Pharmaceuticals trades on the NASDAQ under the ticker symbol "EGRX."
Where is Eagle Pharmaceuticals' stock going? Where will Eagle Pharmaceuticals' stock price be in 2017?
5 brokers have issued twelve-month price targets for Eagle Pharmaceuticals' stock. Their forecasts range from $64.00 to $97.00. On average, they expect Eagle Pharmaceuticals' share price to reach $86.20 in the next twelve months.
When will Eagle Pharmaceuticals announce their earnings?
Eagle Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Thursday, February, 23rd 2017.
Who owns Eagle Pharmaceuticals stock?
Eagle Pharmaceuticals' stock is owned by many different of institutional and retail investors. Top institutional shareholders include ProQuest Associates IV LLC (25.60%), Janus Capital Management LLC (9.62%), Orbimed Advisors LLC (4.35%), State Street Corp (4.23%), JW Asset Management LLC (3.41%) and Perceptive Advisors LLC (3.23%). Company insiders that own Eagle Pharmaceuticals stock include Michael Graves, Proquest Investments Iv, LP, Proquest Management Llc, Sander A Flaum, Sander A Flaum, Scott Tarriff, Steven B Ratoff and Steven L Krill.
Who sold Eagle Pharmaceuticals stock? Who is selling Eagle Pharmaceuticals stock?
Eagle Pharmaceuticals' stock was sold by a variety of institutional investors in the last quarter, including ProQuest Associates IV LLC, Orbimed Advisors LLC, Janus Capital Management LLC, Guggenheim Capital LLC, Opaleye Management Inc., Ranger Investment Management L.P., Allianz Asset Management AG and Kopp Investment Advisors LLC. Company insiders that have sold Eagle Pharmaceuticals stock in the last year include Proquest Investments Iv, LP, Proquest Management Llc, Sander A Flaum, Scott Tarriff and Steven B Ratoff.
Who bought Eagle Pharmaceuticals stock? Who is buying Eagle Pharmaceuticals stock?
Eagle Pharmaceuticals' stock was bought by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC, Castleark Management LLC, State Street Corp, FMR LLC, Nicholas Investment Partners LP, Baird Financial Group Inc., Two Sigma Investments LP and Russell Investments Group Ltd..
How do I buy Eagle Pharmaceuticals stock?
Shares of Eagle Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Eagle Pharmaceuticals stock cost?
One share of Eagle Pharmaceuticals stock can currently be purchased for approximately $72.21.